KoNECT International Conference 2024
Korean biotech is stepping onto the world stage. South Korea has earned recognition as a leader in clinical research as measured by the number of studies conducted annually, the inclusion of its leading medical centers in prestigious global rankings, and government commitments to raising the nation’s stature in this area, and is also getting attention in the global market for its active new drug development activities.
Meet with Us
Our experts will be on the ground at the KoNECT International Conference, showcasing our capabilities across the asset development spectrum. Find us on the stage, at Booth #Hanra 12 in Special Zone or schedule a meeting to discuss your challenge.
Featured Sessions
Navigating FDA IND Preparation: Best Practices and Key Considerations for Successful Submissions
October 29 | 1:30-3:00pm KST
Speaker: InPyo Hong
Director, Regulatory Consulting
PS 2 Talkshow: The Transformation of Clinical Trials in Korea
October 30 | 10:30am-12:00pm KST
Moderator: Sora Lee
Vice President and General Manager, Korea
Clinical Quality by Design (CQbD) and Its Implementation
October 30 | 3:30-5:00pm KST
Speaker: Sunnie (Sun-Young) Han
Director, Clinical Delivery Management
Related Content:
Want to learn more? Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below:
The A-to-Z of Global New Drug Development: Strategic Roadmap for APAC Biopharma
Syneos Health Podcast | Decoding Gen AI’s Potential to Drive More Effective Clinical Trials
Syneos Health Podcast | Turbo-Charging Clinical Trials
WEBINAR | How AI is Supercharging Clinical Trials
Artificial Intelligence, Machine Learning and a New Epoch for Clinical Trials
Is Your Global Risk Management Proactive Enough for Modern PVG Standards?
The Key to Accelerated Global Expansion: Adaptability through a Flexible Outsourcing Model
